Gene Therapy Developers
- Details
- Category: Drug Developers
- Published on Friday, 05 September 2008 16:02
- Hits: 2736
Shenzhen SiBiono GeneTech Co.,Ltd. is a pioneer in developing gene therapy in China. As the first professional company in gene therapy in China, SiBiono has achieved great success. In October 2003, The Recombinant Human Ad-p53 Injection, trademarked as Gendicine, developed independently by Sibiono successfully obtained the Drug license, Production Approval and GMP Certificate from the China State Food & Drug Administration (SFDA).